Value focused pharmaceutical strategy determination with multicriteria decision analysis techniques

Mastorakis, Kostis; Siskos, Eleftherios

doi:10.1016/j.omega.2015.01.020

Cited by 21 publications

(16 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Given that even the slightest uncertainty in the data can render system optimality meaningless from a practical point of view (Bertsimas and Sim 2004) and given recent advancements on robust linear optimisation (Bertsimas and Brown 2009), other prospects for future research include the all-in-one integration of AUGME-CON-R with uncertainty and robustness analysis methods (Van de Ven et al 2019; Mastorakis and Siskos 2016;Ben-Tal et al Ben-Tal et al 2010;Kadzinski et al 2017a, b;Witting et al 2013), thereby avoiding the use of numerous methods, code scripts, or even implementation platforms.…”

Section: Discussionmentioning

confidence: 99%

A robust augmented ε-constraint method (AUGMECON-R) for finding exact solutions of multi-objective linear programming problems

et al. 2020

View full text Add to dashboard Cite

Systems can be unstructured, uncertain and complex, and their optimisation often requires operational research techniques. In this study, we introduce AUGMECON-R, a robust variant of the augmented ε-constraint algorithm, for solving multiobjective linear programming problems, by drawing from the weaknesses of AUG-MECON 2, one of the most widely used improvements of the ε-constraint method. These weaknesses can be summarised in the ineffective handling of the true nadir points of the objective functions and, most notably, in the significant amount of time required to apply it as more objective functions are added to a problem. We subsequently apply AUGMECON-R in comparison with its predecessor, in both a set of reference problems from the literature and a series of significantly more complex problems of four to six objective functions. Our findings suggest that the proposed method greatly outperforms its predecessor, by solving significantly less models in emphatically less time and allowing easy and timely solution of hard or practically impossible, in terms of time and processing requirements, problems of numerous objective functions. AUGMECON-R, furthermore, solves the limitation of unknown nadir points, by using very low or zero-value lower bounds without surging the time and resources required.

show abstract

Section: Discussionmentioning

confidence: 99%

A robust augmented ε-constraint method (AUGMECON-R) for finding exact solutions of multi-objective linear programming problems

et al. 2020

View full text Add to dashboard Cite

show abstract

“…However, recent registration of some new products in the IDL may prompt its market to expand in the midterm. [ 21 22 ]…”

Section: Discussionmentioning

confidence: 99%

Trend analysis of medicine consumption based on therapeutic categories in Iran: 2000–2016

Yektadoost

Ebrahimi

Mashouf³

et al. 2018

J Res Pharm Pract

View full text Add to dashboard Cite

Objective:Iranian healthcare system cost has been remarkably growing during the recent decades. Drug shortages and the economic effects of the sanctions have also exposed the pitfalls and shortcomings of the pharmaceutical system. Moreover, the pharmaceutical system is a major expenditure source for the health system. Pharmaceutical market trend analysis serves as a reliable tool to gather and analyze market and consumption data to take account of the past policies and forecast the future of the market and disease trends.Methods:The present work tries to quantitatively describe and analyze past 17 years of Iranian pharmaceutical market sales data from 2000 to 2016. The anatomical therapeutic chemical-classified drug utilization data obtained from the Iranian Food and Drug Administration were used to analyze the market trends for each therapeutic class and categorize them.Findings:The size of Iranian pharmaceutical market has grown dramatically during the last 5 years reaching to $5.183 billion in 2016 from $3.847 billion in 2011 with a compound annual growth rate of 6.14%. Antidiabetics and antineoplastic agents were one of the most prominent market growth drivers. Introduction of new drug molecules to the market has also contributed to the trend. However, the noncommunicable diseases are gaining momentum in the national disease burden.Conclusion:The market growth necessitates policies to prevent the overwhelming cost burden on the healthcare system which in turn requires well-informed decision-making. Pharmaceutical market trend analysis tries to supply the evidence feed for informed policy-making to forecast, prioritize, and contain the cost burden imposed on the healthcare system by the pharmaceutical sector.

show abstract

“…Neste contexto, a sobrevivência e o crescimento destas organizações estão ligados às suas capabilidades de efetivamente utilizar, nas suas orientações estratégicas e operacionais, grande volume de dados provenientes de diferentes fontes, o que constitui-se atualmente em um fator crítico para o sucesso (Appelbaum, Kogan, Vasarhelyi, & Yan, 2017;Ladeira et al, 2012;Vidgen, Shaw, & Grant, 2017). E isto se evidencia numa conjuntura na qual organizações de todas as partes do mundo e de diversos setores têm adotado a abordagem analítica como um diferencial competitivo em suas operações (Arora & Taylor, 2016;Beltran-Royo, Escudero, & Zhang, 2016;Chae, Yang, Olson, & Sheu, 2014;Gaganis, Hasan, & Pasiouras, 2016;Mastorakis & Siskos, 2016;Matsumoto & Andriosopoulos, 2016;O'Dwyer & Renner, 2011;Oliveira, McCormack, & Trkman, 2012;Trkman, McCormack, Oliveira, & Ladeira, 2010;Troilo, Bouchet, Urban, & Sutton, 2015;Wagner, Brandt, & Neumann, 2016).…”

Section: Introductionunclassified

Panorama da produção científica internacional sobre Business Analytics

Sincorá

Carneiro

Oliveira

2020

RAD

View full text Add to dashboard Cite

Esta pesquisa tem como objetivo analisar a produção acadêmica internacional sobre business analytics (abordagem analítica) obtida em periódicos internacionais disponíveis em sete base de dados. A pesquisa pretende contribuir auxiliando pesquisadores e profissionais interessados no tema com um panorama dos estudos já realizados. A pesquisa avaliou publicações no período entre 2004 e 2016, utilizando-se de técnicas bibliométricas para investigar 47 artigos. Dentre os achados da pesquisa, está que empresas atualmente veem na orientação analítica a oportunidade para obter resultados superiores de desempenho.

show abstract

Value focused pharmaceutical strategy determination with multicriteria decision analysis techniques

Cited by 21 publications

References 19 publications

A robust augmented ε-constraint method (AUGMECON-R) for finding exact solutions of multi-objective linear programming problems

A robust augmented ε-constraint method (AUGMECON-R) for finding exact solutions of multi-objective linear programming problems

Trend analysis of medicine consumption based on therapeutic categories in Iran: 2000–2016

Panorama da produção científica internacional sobre Business Analytics

Contact Info

Product

Resources

About